Gastroenterology
Different gut metabolites can influence the Cryptosporidium parasite’s growth and invasion of intestinal cells. A new study published in mBio claims.
Immune responses to the gut microbiota can be used as biomarkers of clinical course in IBD or as targets for the treatment or prevention of the condition.
The findings suggest that delivery mode, rather than birth canal exposure, has a strong influence on the composition of the infant microbiota.
Modulating the gut microbiota could help to increase Plasmodium-specific immunity, thus reducing disease severity and malaria-associated mortality.
Researches have found that MDD is characterized by disturbances in the gut microbiota and may allow clinicians to better diagnose it.
A two-pronged treatment strategy — consisting of an engineered peptide and an FDA-approved drug — could help to reduce gut inflammation.
The current knowledge of the gut-liver axis in NAFLD may lead to the development of microbiota-based personalized approaches for managing the condition.
A study published in Nature suggests new approaches to improve BMTs as well as treatments for immune-mediated diseases by regulating the gut microbiota.
People with active multiple sclerosis have high levels of particular gut antibodies, called immunoglobulin A (IgA), in the central nervous systems.
Individuals with autism are unable to break down some environmental toxins, which could allow the toxins to enter the bloodstream and injure brain cells.
